In addition, the FCM assay results supported that YAP1 overexpression also suppressed PTX-induced cell death in PR-BC cells with ANXA6 overexpression (Figures 6E,F), implying that knockdown of ANXA6 increased susceptibility of PR-BC cells to high-dose PTX treatment via downregulating YAP1. Here, YAP1 is linked to breast cancer.